New migraine clinical trial guidelines
January 24, 2012 in Diseases, Conditions, Syndromes
Experts from the International Headache Society (IHS) have developed new recommendations for conduct of acute and preventive migraine clinical trials. The third edition of Migraine Clinical Trials Guidelines is now available in the IHS journal Cephalalgia, which is published by SAGE.
The new guidelines represent an expert consensus summary, and recommend a contemporary, standardized, and evidence-based approach to investigators conducting and reporting randomised, controlled migraine clinical trials.
Migraine clinical research has increased exponentially since the last set of guidelines was published. Clinical researchers and pharmaceutical companies have accumulated further experience, and the trend is towards large, multi-national and multi-centre studies. Given these developments, it was timely to bring the guidelines up to date.
The IHS stresses that it endorses adherence to the guidelines unless there is scientific justification to deviate from them. They represent research practice parameters and are the highest level in the hierarchy of evidence-based recommendations in the absence of published standards of research practice.
Trials for acute migraine are addressed in the new guidelines' first section, followed by discussions and recommendations relating to clinical trials for migraine prevention. This includes short-term prevention or 'mini-prophylaxis' for predictable migraine attacks, such as those associated with menses. Sub-sections include: patient selection, trial design, evaluation of results and statistics. A toolbox for each type of trial (acute and prevention) is provided at the end.
The guidelines do not include broader discussions of clinical trials methodologies or ethical considerations, which are published elsewhere.
The publication supersedes previous guidelines. The first edition, published by the Clinical Trials Subcommittee of the IHS in 1991, highlighted the complex nature of migraine clinical trial methodologies and offered a road map to clinical investigators who were interested in the field. Widely adopted, these guidelines were the impetus for similar guidelines' development for tension-type headache and cluster headaches as well.
A second edition was published in 2000 and formed the basis for the European Medicines Agency's 2007 publication, Guidelines on Clinical Investigation of Medicinal Products for the Treatment of Migraine.
Despite these former publications, corresponding author Peer Tfelt-Hansen from the Danish Headache Center at the University of Copenhagen says that adherence to the recommendations in the guidelines for clinical trials on acute migraine treatment has not been overwhelming. For instance, less than a third of 145 acute treatment trials cited between 2002 and 2008 used freedom from pain after two hours as their measure of efficacy, as recommended. Almost 40 percent of trials were instead using a decrease in pain levels as a measure of a treatment's effectiveness.
Even so, freedom from pain as the primary measure of treatment efficacy is gaining ground in clinical trials today. The updated guidelines are essential reading for those active in migraine research. Many more will benefit, as migraines affect more than ten percent of the world's population.
More information: Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators is published today, 24th January 2012, in Cephalalgia
Provided by SAGE Publications
-
A primer on migraine headaches
Feb 16, 2010 |
not rated yet |
0
-
Substantial recovery rate with placebo effect in headache treatment
May 23, 2011 |
not rated yet |
0
-
Fewer headaches on the horizon thanks to latest guidelines
Jan 06, 2010 |
not rated yet |
0
-
A pill to prevent migraine? Discovery of migraine gene could put it on the horizon
Jun 01, 2011 |
not rated yet |
0
-
Migraine increases risk of severe skin sensitivity and pain
Apr 21, 2008 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
New research identifies practice changes to improve value and quality of GI procedures
There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week (DDW).
Diseases, Conditions, Syndromes
4 hours ago |
not rated yet |
0
Consuming coffee linked to lower risk of detrimental liver disease, study finds
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
Diseases, Conditions, Syndromes
5 hours ago |
not rated yet |
0
|
New case of SARS-like virus in Saudi: ministry
A new case of the deadly coronavirus has been detected in Saudi Arabia where 15 people have already died after contracting it, the health ministry announced on Saturday on its Internet website.
Diseases, Conditions, Syndromes
17 hours ago |
not rated yet |
0
Little evidence for prediction rules for low back pain
(HealthDay)—Few randomized clinical trials have been done to assess clinical prediction rules for patients with lower back pain, and the trials that have been done are of low quality and do not provide ...
Diseases, Conditions, Syndromes
May 17, 2013 |
not rated yet |
0
|
New malaria test kit gives a boost to elimination efforts worldwide
A new, highly sensitive blood test that quickly detects even the lowest levels of malaria parasites in the body could make a dramatic difference in efforts to tackle the disease in the UK and across the world, according to ...
Diseases, Conditions, Syndromes
May 17, 2013 |
not rated yet |
0
Ketamine shows significant therapeutic benefit in people with treatment-resistant depression
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
Research examines new methods for managing digestive health
Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.
New smartphone application improves colonoscopy preparation
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...
New research identifies risks, interventions for children's GI health
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
US psychiatry gets makeover in new manual
The latest makeover to a massive psychiatric tome honored by some, reviled by others and even called the "Bible" of mental disorders is being released Saturday with a host of new changes.
New colonoscope provides ground-breaking view of colon
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...